Stocks Down Under Videos

Get a 3-month FREE TRIAL to CONCIERGE now!

Concierge gives you timely BUY and SELL alerts on ASX-listed stocks

Test Concierge Now!

Blinklab (ASX:BB1) is gearing up for FDA approval and commercial rollout

January 23, 2025

BB1, Blinklab

Blinklab (ASX:BB1)

We spoke to Henk-Jan Boele, CEO of Blinklab (ASX:BB1), about the company’s roadmap to FDA approval and the subsequent commercial roll out.

Because Blinklab is filing for FDA 510(k) clearance, this roadmap should be a lot shorter than for your typical life sciences company.

 

Looking for the Best ASX Life Sciences Stocks to invest in right now?

 

 

View All